Mansoureh Sabzalizadeh

Dr. Mansoureh Sabzalizadeh


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Addiction & Health
Verified
Journal Article
Open access
PDF file
MFMelika Farhadi
Melika Farhadi
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh
ASAli Shamsara
Ali Shamsara
MAMohammad Reza Afarinesh
Mohammad Reza Afarinesh
Background: Opioids can lead to mood disorders, anxiety, depression, and cognitive impairment. Valproic acid (VPA) has neuroprotective effects that can prevent neural degeneration. This study aims to examine the impact of VPA on learning, social interaction, and depression in mice dependent on morphine. Methods: Subjects were divided into four groups and received injections of saline, VPA, morphine, or a combination of VPA and morphine for eight days. Behavioral tests were conducted on day 8, and then administration of VPA and morphine was stopped, leading to spontaneous withdrawal syndrome. Behavioral tests were repeated on day 11, and histological analysis was performed on the hippocampus. Findings: The preference index (PI%) decreased in the novel object recognition test in the VPA and morphine sulfate (MOR) groups compared to the control (CTL) group in the chronic phase. The concomitant administration of VPA and morphine caused an increase in social interaction criteria in both the chronic and withdrawal phases. The decrease in immobility time in the VPA and MOR+VPA groups compared to the CTL group in the withdrawal phase was not statistically significant in the tail suspension test (TST). In Nissl staining, the combination of MOR+VPA led to a significant decrease in the DC/All cell ratio compared to the individual MOR and VPA groups (P<0.05). Conclusion: VPA may improve social relationships and depression indices during morphine withdrawal. VPA may potentially mitigate the cellular changes in the CA1 of the hippocampus induced by morphine.

20 December 2024 in Physiology & Behavior
Verified
Journal Article
Closed access
MFMelika Farhadi
Melika Farhadi
MAMohammad Reza Afarinesh
Mohammad Reza Afarinesh
VSVahid Sheibani
Vahid Sheibani
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh

1 January 2024 in Translational Neuroscience
Verified
Journal Article
Open access
PDF file
ADAli Derakhshani
Ali Derakhshani
FTFarahnaz Taheri
Farahnaz Taheri
NGNima Geraminia
Nima Geraminia
LMLily Mohammadipoor-Ghasemabad
Lily Mohammadipoor-Ghasemabad
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh
VSVahid Sheibani
Vahid Sheibani
Introduction: Cortical lesions can cause major sensory and motor impairments, representing a significant challenge in neuroscience and clinical medicine. Limbal mesenchymal stem cells (LMSCs), renowned for their remarkable ability to proliferate and distinct characteristics within the corneal epithelium, offer a promising opportunity for regenerative treatments. This study aimed to assess whether the transplantation of LMSCs could improve tactile ability in rats with lesions of the barrel cortex. Methods: In this experimental study, we divided 21 rats into three groups: a control group, a lesion group with cortical cold lesion induction but no stem cell treatment, and a group receiving LMSC transplantation following cold lesion induction. We conducted 3-week sensory assessments using a texture discrimination test and an open-field test. We also performed Nissl staining to assess changes on the cellular level. Results: Rats in the LMSC transplantation group demonstrated significant improvements in their ability to discrimination textures during the second and third weeks compared to those in the lesion group. The open-field test results showed an increased exploratory behavior of rats in the LMSC transplantation group by the third week compared to the lesion group. Additionally, Nissl staining revealed cellular alterations in the damaged cortex, with a significant distinction observed between rats in the LMSCs and lesion group. Conclusion: The findings suggest that LMSC transplantation enhances sensory recovery in rats with cortical lesions, particularly their ability to discriminate textures. LMSC transplantation benefits brain tissue reparation after a cold lesion on the somatosensory cortex.

1 May 2022 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
SKSina Kakooei
Sina Kakooei
MAMohammad Reza Afarinesh
Mohammad Reza Afarinesh
MPMasoud Parirokh
Masoud Parirokh
Reza NikzadReza Nikzad
Reza Nikzad
MMMahshid Mostafavi
Mahshid Mostafavi
VSVahid Sheibani
Vahid Sheibani
Introduction: Success in anesthesia administration relieves the perception of pain during surgery. Lidocaine is the most commonly used local anesthetic agent in clinical medicine. Moreover, anesthetic agents’ temperature changes can influence cell membrane permeability. Here, the effectiveness of different temperatures of Lidocaine (Lid.) on anesthesia success rate has been investigated in rats. Methods: Wistar male rats were pretreated by fast injection of lidocaine or saline into the hind paw or intradermal cheek at Room Temperature (RT) and Body Temperature (BT) (22°C and 37°C, respectively). Then, rat behaviors were evaluated by formalin-induced hind paw pain and orofacial pain tests, respectively. Moreover, using a single-unit recording technique, the spontaneous activity of the marginal nerve was recorded at room temperature in the RT-Lid. and BT-Lid. groups. Results: Data analysis revealed that lidocaine had significant antinociceptive effects in both the BT-Lid. and RT-Lid. groups compared to the control groups (P<0.05). Also, the number of spikes in the BT-Lid. and RT-Lid. groups were significantly lower than their baselines (P<0.05). However, lidocaine at body temperature decreased the total time spent licking the hind paw, the number of lip rubbings, and the number of spikes firing by about 10%-15% compared to room temperature. Conclusion: In both behavioral and neural levels of the study, our results showed that an increase in the temperature of lidocaine toward body temperature could increase anesthesia success rate compared to administration of lidocaine at room temperature. These findings can be considered in the treatment of patients.
1

22 October 2025 in Cognitive Processing
Verified
Journal Article
Closed access
PDF file
SDSina Delshad
Sina Delshad
MAMohammad Farajli Abbasi
Mohammad Farajli Abbasi
NGNima Geraminia
Nima Geraminia
ERElahe Rohani
Elahe Rohani
FVFarzaneh Vafaee
Farzaneh Vafaee
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh

11 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MMMohammed Mahdi-Abdulamir
Mohammed Mahdi-Abdulamir
SMSomayeh Karami Mohajeri
Somayeh Karami Mohajeri
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh
FAFatima Adnan Alzubaidi
Fatima Adnan Alzubaidi
FAFatemeh Abedi
Fatemeh Abedi
BackgroundValproic acid (VPA) is an important antiepileptic medication, but its continuous use is limited by serious neurotoxic side effects, including cognitive impairment and neuronal cell death. In this study, we examined how co-administering VPA with melatonin (MEL) and vitamin B6 could help control seizures while avoiding an increase in VPA-related neurotoxicity, using PTZ-induced seizures as a model.MethodsMale Wistar mice were assigned at random to five groups (n=8 in each group): control animals receiving saline, animals treated with VPA at 250 mg/kg, animals treated with VPA at 500 mg/kg, animals given VPA 250 mg/kg combined with MEL (10 mg/kg) and B6 (50 mg/kg), and animals given VPA 500 mg/kg combined with MEL and B6. Injections were given intraperitoneally once daily for 14 days. After treatment, seizures were triggered with PTZ at 35 mg/kg. Seizure outcomes, including latency, overall duration, and severity, were determined using the Modified Racine Scale. Behavioral performance was evaluated with Novel Object Recognition (NOR), Novel Texture Recognition (NTR), shuttle box avoidance, and the Elevated Plus Maze (EPM). Finally, histopathological alterations in the hippocampus were assessed using Nissl staining.ResultsThe combination therapy (VPA 500 mix) markedly increased seizure onset latency (70.0 ± 0.0 s vs. 44.7 ± 4.9 s in controls, p<0.01) and shortened seizure duration (586.0 ± 57.8 s vs. 961.2 ± 114.7 s, p<0.01) compared with the control group. All groups treated with VPA completely eliminated stage 6 seizures. The VPA 500 mix group also showed better cognitive outcomes, with a 192% rise in the NOR discrimination index and a 183% increase in the shuttle box avoidance index compared to controls (p<0.01). On histopathological analysis, VPA 500 mix preserved 71% of intact neurons and brought the degenerated cell ratio back toward normal when compared with VPA 500 monotherapy (p<0.001). Anxiolytic effects were evident as well, indicated by increased time spent in the open arms of the EPM, while locomotor activity remained unchanged.ConclusionCoadministration of VPA with melatonin and vitamin B6 produces synergistic effects, significantly improving seizure control, preserving cognitive function, and providing robust neuroprotection. This triple combination represents a promising adjunctive strategy to overcome VPA-induced neurotoxicity in epilepsy management.